Terrestrial and aquatic mammals of the Pantanal.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 21537603)

Published in Braz J Biol on April 01, 2011

Authors

C J R Alho1, G Camargo, E Fischer

Author Affiliations

1: Programa de Pós-graduação em Ambiente e Desenvolvimento Regional, Universidade Anhanguera-Uniderp, CEP 79037-280, Campo Grande, MS, Brazil. alho@unb.br

Articles by these authors

(truncated to the top 100)

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A (1992) 3.61

Relationship between Energy-dependent Phosphate Uptake and the Electrical Membrane Potential in Lemna gibba G1. Plant Physiol (1981) 3.03

Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr (1998) 2.27

SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci (1999) 2.21

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med (1998) 2.19

IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol (1991) 2.03

Alcohol and drug disorders among physically abusive and neglectful parents in a community-based sample. Am J Public Health (1994) 1.96

A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A (1996) 1.87

Reduced postoperative pancreatic fistula rate after pancreatogastrostomy versus pancreaticojejunostomy. J Gastrointest Surg (2008) 1.83

Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73

Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg (1996) 1.65

Hypothermia during elective abdominal aortic aneurysm repair: the high price of avoidable morbidity. J Vasc Surg (1995) 1.64

High-risk intrahospital transport of critically ill patients: safety and outcome of the necessary "road trip". Crit Care Med (1995) 1.54

Effects of acid-base correction on hemodynamics, oxygen dynamics, and resuscitability in severe canine hemorrhagic shock. Crit Care Med (1994) 1.54

Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51

Effects of intravenous IL-8 administration in nonhuman primates. J Immunol (1992) 1.44

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med (1991) 1.44

Acute acalculous cholecystitis. J Am Coll Surg (1995) 1.43

Effects of pentoxifylline on hemodynamics, oxygen transport, and tissue metabolism in experimental, severe hemorrhagic shock. Crit Care Med (1991) 1.41

Genetics and regulation of chitobiose utilization in Borrelia burgdorferi. J Bacteriol (2001) 1.41

Descending aortic cannulation during emergent thoracotomy for blunt traumatic cardiac arrest. J Trauma (1999) 1.38

Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun (2000) 1.34

A ninth complementation group in xeroderma pigmentosum, XP I. Mutat Res (1985) 1.26

Inhibition of lymphocyte proliferation by factor(s) produced by Schistosoma mansoni. Eur J Immunol (1977) 1.24

Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes. Proc Natl Acad Sci U S A (1977) 1.22

Pollen-based quantitative reconstructions of Holocene regional vegetation cover (plant-functional types and land-cover types) in Europe suitable for climate modelling. Glob Chang Biol (2014) 1.21

Preparation of the FhuA (TonA) receptor protein from cell envelopes of an overproducing strain of Escherichia coli K-12. J Bacteriol (1986) 1.20

Occupational disease in New York State: a comprehensive examination. Am J Ind Med (1989) 1.19

Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol (2001) 1.15

Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol (1998) 1.14

Intestinal sugar transport in experimental diabetes. Diabetes (1981) 1.13

Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA. Infect Immun (2002) 1.12

Improving biological control by combining biocontrol agents each with several mechanisms of disease suppression. Phytopathology (2002) 1.12

Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes. Eur J Immunol (1990) 1.11

[Arrhythmias and symptoms during long-term ECG in ambulatory patients]. Schweiz Rundsch Med Prax (1984) 1.09

The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP. J Biol Chem (1982) 1.09

Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun (2001) 1.08

Spontaneous in vitro malignant transformation in a xeroderma pigmentosum fibroblast line. Int J Cancer (1983) 1.08

Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur J Immunol (2001) 1.01

Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions. J Clin Invest (1985) 1.01

[Analytical characterization of palatinit (author's transl)]. Z Lebensm Unters Forsch (1979) 1.00

Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. J Immunol (1987) 0.98

Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c. Scand J Immunol (1988) 0.98

Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest (1997) 0.98

Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol (1980) 0.98

Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor. J Immunol (1986) 0.97

Health costs of occupational disease in New York State. Am J Ind Med (1989) 0.97

Inhibition of complement activation by natural sulfated polysaccharides (fucans) from brown seaweed. Mol Immunol (1994) 0.97

One-year survival and neurological outcome after pediatric cardiopulmonary resuscitation. Intensive Care Med (2002) 0.96

Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics. HIV Med (2012) 0.96

Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells. J Immunol (1991) 0.96

Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand J Immunol (1993) 0.96

Localization of the chaperone domain of FKBP52. J Biol Chem (2001) 0.95

Mouse monoclonal antibodies to the human C3b receptor. Mol Immunol (1985) 0.94

Xeroderma pigmentosum patients from Germany: clinical symptoms and DNA repair characteristics. Arch Dermatol Res (1982) 0.94

Overproduction of the proFhuA outer membrane receptor protein of Escherichia coli K-12: isolation, properties, and immunocytochemical localization at the inner side of the cytoplasmic membrane. Arch Microbiol (1986) 0.94

Identification of surface molecules on salivary glands of the mosquito, Aedes aegypti, by a panel of monoclonal antibodies. Insect Biochem Mol Biol (1999) 0.94

Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol (1986) 0.94

Hand-assisted laparoscopic splenectomy for giant spleens. Surg Endosc (2003) 0.93

Harry M. Vars award. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxin. JPEN J Parenter Enteral Nutr (1990) 0.93

Utility of illness severity scoring for prediction of prolonged surgical critical care. J Trauma (1996) 0.92

Comparison of APACHE II and III scoring systems for mortality prediction in critical surgical illness. Arch Surg (1995) 0.92

Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants. Photodermatol (1986) 0.92

Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA. Proc Natl Acad Sci U S A (1978) 0.92

A prospective comparison of two multiple organ dysfunction/failure scoring systems for prediction of mortality in critical surgical illness. J Trauma (1994) 0.92

Endothelial cells of the kidney vasa recta express the urea transporter HUT11. Kidney Int (1997) 0.90

Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia. Blood (1995) 0.90

Schistosoma mansoni: autoantibodies and polyclonal B cell activation in infected mice. Clin Exp Immunol (1981) 0.89

A new ultra-pressure liquid chromatography method for the determination of biogenic amines in cheese. J Chromatogr A (2009) 0.89

CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus. Eur J Immunol (1994) 0.89

Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement. J Immunol (1983) 0.88

Technical assistance offered to community health programs through a resource model. Public Health Rep (1985) 0.88

Schizophrenia: a network crisis. Schizophr Bull (1981) 0.88

The human C3b receptor (CR1). Adv Nephrol Necker Hosp (1989) 0.88

Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. J Immunol (1988) 0.88

Preembryo biopsy and analysis of blastomeres by in situ hybridization. Am J Obstet Gynecol (1990) 0.87

Characterization of monoclonal antihuman-B-cell antibody BL13 as an anti-C3d-receptor (CR2) antibody. Scand J Immunol (1986) 0.87

Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells. Int Immunol (1998) 0.87

[Demonstration of chronic insertion tendinitis on the humeral epicondyle by means of soft tissue radiography (author's transl)]. Fortschr Geb Rontgenstr Nuklearmed (1973) 0.86

Side effects of clozapine. Psychopharmacology (Berl) (1989) 0.86

Impact of exogenous growth hormone on host preservation and tumor cell-cycle distribution in a rat sarcoma model. J Surg Res (1991) 0.86

The Linderniaceae and Gratiolaceae are further lineages distinct from the Scrophulariaceae (Lamiales). Plant Biol (Stuttg) (2005) 0.86

Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scand J Immunol (1992) 0.85

Active immunisation during an outbreak of hepatitis A in a German day-care centre. Vaccine (2006) 0.85

Nonspecific suppressor cell activity and specific cellular unresponsiveness in rat schistosomiasis. Eur J Immunol (1979) 0.84

Sigmoidal substrate saturation curves in Michaelis-Menten mechanism as an artefact. Acta Biochim Biophys Acad Sci Hung (1975) 0.84

Pseudomembranous tracheobronchitis due to Bacillus cereus. Clin Infect Dis (2001) 0.83

Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery (1995) 0.83

PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. J Surg Res (1995) 0.83

Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J Immunol (1992) 0.83

Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23. Eur J Immunol (1996) 0.83

Toxicity of copper to Porcellio scaber Latr. (Isopoda) under different nutritional status. Bull Environ Contam Toxicol (1996) 0.82

Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1). J Biol Chem (1989) 0.82

Alterations of preliminary readings on radiographic examinations minimally affect outcomes of trauma patients discharged from the emergency department. J Trauma (2000) 0.82

Comparison of peripheral blood leukocyte kinetics after live Escherichia coli, endotoxin, or interleukin-1 alpha administration. Studies using a novel interleukin-1 receptor antagonist. Ann Surg (1993) 0.82

Influence of adrenergic blocking agents upon morphine and catecholamine analgesic effect. Experientia (1968) 0.82

Induction of an intestinal epithelial sugar transport system by high blood sugar. Experientia (1977) 0.82

Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b. Mol Immunol (1983) 0.82

Decreased blood platelet volume and count in patients with liver disease. Scand J Gastroenterol (1984) 0.82

Complement enhancement of HIV infection is mediated by complement receptors. Immunopharmacology (1993) 0.82